WASHINGTON - The U.S. drug regulator on Monday expanded the use of a third shot of Pfizer Inc.'s coronavirus vaccine to children aged 12 to 15 and also shortened the wait time for a booster shot from six to five months.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
